Clinical Trial Update: A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 clinical trial evaluating AK112 as consolidation therapy for patients with limited-stage small-cell lung cancer wh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• AK112

Snippet

Sponsor: Akeso | Conditions: Small Cell Lung Cancer | Phase 3 | Status: RECRUITING